📊 AMN Key Takeaways
Is Amn Healthcare Services Inc. (AMN) a Good Investment?
AMN Healthcare faces significant profitability challenges with negative operating and net margins despite maintaining positive free cash flow, indicating operational distress masked by working capital management. The company's leveraged balance sheet (1.19x debt-to-equity) combined with negative interest coverage and deteriorating revenue (-8.5% YoY) creates a precarious financial position vulnerable to further operational headwinds.
AMN Healthcare’s fundamentals are under pressure: revenue is declining, margins have turned negative, and returns on equity and assets are both negative, indicating a meaningful deterioration in earnings quality. While operating cash flow and free cash flow remain solid, weak liquidity, elevated leverage, and negative interest coverage suggest the balance sheet has limited flexibility if profitability does not recover soon.
Why Buy Amn Healthcare Services Inc. Stock? AMN Key Strengths
- Strong free cash flow generation of $233.8M despite unprofitable operations, demonstrating cash conversion capability
- Gross margin of 28.3% provides some buffer for cost management and operational improvements
- Positive operating cash flow of $269.5M shows underlying business can generate cash despite GAAP losses
- Operating cash flow of $269.46M and free cash flow of $233.83M show the business still generates meaningful cash despite earnings pressure
- Gross margin of 28.3% indicates the core service model retains some underlying pricing and cost structure resilience
- Equity remains positive at $642.11M, providing a remaining capital cushion despite recent losses
AMN Stock Risks: Amn Healthcare Services Inc. Investment Risks
- Negative operating margin of -2.0% and net margin of -3.5% indicate core business is unprofitable at current revenue levels
- Revenue declining 8.5% year-over-year with no clear path to profitability suggests market headwinds or competitive pressures
- High leverage (1.19x debt-to-equity) with $767.1M long-term debt combined with negative interest coverage ratio of -3.3x creates refinancing and solvency risk
- Current ratio of 0.94x signals potential liquidity constraints; company cannot fully cover short-term obligations with current assets
- Negative ROE (-14.9%) and ROA (-4.6%) demonstrate shareholder capital is being eroded
- Revenue declined 8.5% YoY while operating income fell to a loss, signaling weakening demand and operating deleverage
- Current and quick ratios of 0.94x indicate tight near-term liquidity and limited working capital buffer
- Debt-to-equity of 1.19x and negative interest coverage of -3.3x raise refinancing and balance-sheet risk if earnings stay weak
Key Metrics to Watch
- Quarterly revenue trend and ability to stabilize market share
- Path to operating profitability and timeline to positive operating margin
- Free cash flow sustainability and debt reduction capability
- Current ratio improvement and working capital management
- Gross margin sustainability amid pricing and cost pressures
- Operating margin and interest coverage for signs of earnings recovery
- Revenue trend versus free cash flow sustainability
Amn Healthcare Services Inc. (AMN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
AMN Profit Margin, ROE & Profitability Analysis
AMN vs Services Sector: How Amn Healthcare Services Inc. Compares
How Amn Healthcare Services Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Amn Healthcare Services Inc. Stock Overvalued? AMN Valuation Analysis 2026
Based on fundamental analysis, Amn Healthcare Services Inc. shows some fundamental concerns relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Amn Healthcare Services Inc. Balance Sheet: AMN Debt, Cash & Liquidity
AMN Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Amn Healthcare Services Inc.'s revenue has remained relatively flat over the 5-year period, with a 5% decline. The most recent EPS of $5.36 reflects profitable operations.
AMN Revenue Growth, EPS Growth & YoY Performance
AMN Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $634.5M | $7.0M | $0.18 |
| Q2 2025 | $658.2M | $16.2M | $0.42 |
| Q1 2025 | $689.5M | -$1.1M | $-0.03 |
| Q3 2024 | $687.5M | $7.0M | $0.18 |
| Q2 2024 | $740.7M | $16.2M | $0.42 |
| Q1 2024 | $820.9M | $17.3M | $0.45 |
| Q3 2023 | $853.5M | $53.2M | $1.39 |
| Q2 2023 | $991.3M | $60.9M | $1.55 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Amn Healthcare Services Inc. Dividends, Buybacks & Capital Allocation
AMN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Amn Healthcare Services Inc. (CIK: 0001142750)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AMN
What is the AI rating for AMN?
Amn Healthcare Services Inc. (AMN) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (SELL) with 80% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AMN's key strengths?
Claude: Strong free cash flow generation of $233.8M despite unprofitable operations, demonstrating cash conversion capability. Gross margin of 28.3% provides some buffer for cost management and operational improvements. ChatGPT: Operating cash flow of $269.46M and free cash flow of $233.83M show the business still generates meaningful cash despite earnings pressure. Gross margin of 28.3% indicates the core service model retains some underlying pricing and cost structure resilience.
What are the risks of investing in AMN?
Claude: Negative operating margin of -2.0% and net margin of -3.5% indicate core business is unprofitable at current revenue levels. Revenue declining 8.5% year-over-year with no clear path to profitability suggests market headwinds or competitive pressures. ChatGPT: Revenue declined 8.5% YoY while operating income fell to a loss, signaling weakening demand and operating deleverage. Current and quick ratios of 0.94x indicate tight near-term liquidity and limited working capital buffer.
What is AMN's revenue and growth?
Amn Healthcare Services Inc. reported revenue of $2.7B.
Does AMN pay dividends?
Amn Healthcare Services Inc. does not currently pay dividends.
Where can I find AMN SEC filings?
Official SEC filings for Amn Healthcare Services Inc. (CIK: 0001142750) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AMN's EPS?
Amn Healthcare Services Inc. has a diluted EPS of $-2.48.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AMN a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Amn Healthcare Services Inc. has a SELL rating with 80% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is AMN stock overvalued or undervalued?
Valuation metrics for AMN: ROE of -14.9% (sector avg: 16%), net margin of -3.5% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy AMN stock in 2026?
Our dual AI analysis gives Amn Healthcare Services Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AMN's free cash flow?
Amn Healthcare Services Inc.'s operating cash flow is $269.5M, with capital expenditures of $35.6M. FCF margin is 8.6%.
How does AMN compare to other Services stocks?
Vs Services sector averages: Net margin -3.5% (avg: 10%), ROE -14.9% (avg: 16%), current ratio 0.94 (avg: 1.5).